Skip to main content
Premium Trial:

Request an Annual Quote

Broadlane to Supply Cepheid's Molecular Dx Line to US Medical Facilities

NEW YORK (GenomeWeb News) – Healthcare supply company Broadlane will sell Cepheid’s molecular diagnostics instruments, reagents, and services to its customers, which include more than 20,000 healthcare facilities in the US, Cepheid said today. 
 
Broadlane’s client base includes acute care hospitals, ambulatory care facilities, and physician’s offices, Cepheid said.
 
The agreement covers Cepheid’s GeneXpert System and Xpert tests, which includes the company’s test kit for infections caused by methicillin-resistant Staphylococcus aureus.
 
Cepheid pointed out that a recently released study estimates that there were nearly 95,000 cases of MRSA in the US in 2005, resulting in around 18,650 deaths.
 
Financial terms of the agreement were not released.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.